Monthly Archives: August 2024

//August

MHRA Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd)

Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) Drug alert number: EL (24)A/35 MDR number: MDR 113-05/24 Date issued: 08 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) Company name: Accord-UK Ltd Product name: Trandolapril 0.5mg [...]

The post MHRA Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) appeared first on Community Pharmacy England.

By |August 8th, 2024|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd)

Latuda®(lurasidone) tablets – retrospective reimbursement price adjustment for April 2024

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has retrospectively adjusted the reimbursement prices for all strengths of Latuda® (lurasidone) tablets dispensed in April 2024. On 1 April 2024, there was an increase in the NHS list prices of Latuda® (all strengths) manufactured [...]

The post Latuda®(lurasidone) tablets – retrospective reimbursement price adjustment for April 2024 appeared first on Community Pharmacy England.

By |August 7th, 2024|Lexpos News|Comments Off on Latuda®(lurasidone) tablets – retrospective reimbursement price adjustment for April 2024

EpiPen® and Jext® – reimbursement price changes for July 2024

Following representations from Community Pharmacy England on behalf of community pharmacy contractors, the Department of Health and Social Care (DHSC) has redetermined the reimbursement prices for EpiPen® and Jext® (adrenaline) preparations dispensed in July 2024. On 1 July 2024, there was an increase in the NHS list prices of EpiPen® and Jext® preparations manufactured by [...]

The post EpiPen® and Jext® – reimbursement price changes for July 2024 appeared first on Community Pharmacy England.

By |August 7th, 2024|Lexpos News|Comments Off on EpiPen® and Jext® – reimbursement price changes for July 2024

Retrospective pricing adjustments for Aptamil products

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has confirmed that the following products have been granted upward retrospective pricing adjustments due to out of date product and/or pricing information held on NHS dictionary of medicines and devices (dm+d). A change to the reimbursement will apply to prescriptions dispensed [...]

The post Retrospective pricing adjustments for Aptamil products appeared first on Community Pharmacy England.

By |August 7th, 2024|Lexpos News|Comments Off on Retrospective pricing adjustments for Aptamil products

MHRA Class 4 Medicines Defect Information: Omeprazole products (Sandoz Limited)

Class 4 Medicines Defect Information: Omeprazole products (Sandoz Limited) Drug alert number: EL (24)A/34 Date issued: 07 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Omeprazole products (Sandoz Limited) Company name: Sandoz Limited Product name: Omeprazole 10mg gastro-resistant capsules, PL 04416/0651 SNOMED Code: 3753411000001102 [...]

The post MHRA Class 4 Medicines Defect Information: Omeprazole products (Sandoz Limited) appeared first on Community Pharmacy England.

By |August 7th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Omeprazole products (Sandoz Limited)